48 results
Page 2 of 3
6-K
EX-99.1
1yvdpgac5 3bwwv95zx
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
gopd2ufmdgq0pzf
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
S-8
EX-99.2
bz0do3f3475zzvpsi
24 May 19
Registration of securities for employees
5:16pm
6-K
EX-99.1
0aa 0rs3wykavz
29 Mar 19
Current report (foreign)
6:02am
6-K
EX-99.1
h1dvwy53uj
29 Mar 19
Current report (foreign)
6:00am
6-K
EX-99.1
l3b mf0e8qjopt
23 Oct 18
Positive Trial Results with Filgotinib In Psoriatic Arthritis and Ankylosing Spondylitis Both Published In the Lancet
7:59am
424B5
06cnki8dt
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-1.1
z30siitpbl06oy7uyq0
18 Apr 17
Galapagos announces launch of proposed public offering
12:00am
424B5
tarf1yv8 5bsh4
18 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
fy14 vrzej7f24a
17 Apr 17
Prospectus supplement for primary offering
12:00am